Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study
The occurrence of GTN was higher after CHMCF than after typical complete hydatidiform moles. Despite the heightened risk of premature birth, some patients with CHMCF who maintain their pregnancies can successfully deliver live babies. Informed consent is essential for patients with CHMCF when considering pregnancy continuation. A team approach involving gynecological oncologists, obstetricians, and neonatologists is essential for effective diagnosis and treatment.
Authors
- Kosuke Yoshida (ORCID: https://orcid.org/0000-0003-1484-4872)
- Eiko Yamamoto (ORCID: https://orcid.org/0000-0002-0517-5091)
- Seiji Sumigama (ORCID: https://orcid.org/0000-0001-6913-3731)
- Mayu Shibata (ORCID: https://orcid.org/0000-0003-0228-5858)
- Kimihiro Nishino (ORCID: https://orcid.org/0000-0002-2228-8450)
- Kaoru Niimi (ORCID: https://orcid.org/0000-0003-4546-9606)
- Hiroaki Kajiyama (ORCID: https://orcid.org/0000-0003-0493-1825)
- Yuko Yasui
- Yuki Nishiko
Institutions
- Nagoya University Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1007/s10147-025-02815-0
- Citations
- 1
- Primary Topic
- Gestational Trophoblastic Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Nagoya University
- Japan Society for the Promotion of Science